Efati M et al., 2025-04-10: Rat study finding leucomethylene blue, the reduced form of methylene blue, protected against acetaminophen-induced liver injury with efficacy comparable to N-acetylcysteine for most endpoints.
can effectively ameliorate APAP-induced toxicity in rats, with comparable efficacy to N-acetylcysteine with respect to most complications of acetaminophen-induced toxicity in rats.
Efati M et al., 2025-04-10: Rat study finding leucomethylene blue, the reduced form of methylene blue, protected against acetaminophen-induced liver injury with efficacy comparable to N-acetylcysteine for most endpoints. C10 (liver, animal). Study type: animal experiment in rats; Department of Clinical Biochemistry, Faculty of Medicine (country not stated in the abstract). Agent: leuco-methylene blue, not the marketed methylene blue product; dose not stated in the abstract text captured. Comparator: N-acetylcysteine. Funders/conflicts not stated. MEDIUM because the abstract does not give the doses. Drug Chem Toxicol 2025;48:888-900. Study type: animal.
